Notice on Convening the 2025 Annual General Meeting
Filed with SSE · · 10 pages · Chinese
Earlier from Sinotherapeutics
- Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference
- Indicative Announcement on Equity Change of Shareholder with Over 5% Shares Reaching an Integral Multiple of 1% and 5% Scale
- Announcement on Resolutions of the 25th Meeting of the 2nd Board of Directors
- Publicity Explanation and Verification Opinions of the Remuneration and Appraisal Committee of the Board of Directors on List of Initially Granted Incentive Objects in the 2025 Restricted Stock Incentive Plan
- Announcement on Voluntary Disclosure of Sinotherapeutics® Tomato Red Grape Seed Extract Tablets Obtaining the Domestic Health Food Registration Certificate
Later from Sinotherapeutics
- Announcement on Voluntary Disclosure of Obtaining the Colombian INVIMA Approval for Bupropion Hydrochloride Extended-release Tablets
- Senior Management Member" -- Announcement on Completing Term Change and Election of the Board of Directors and Appointing Senior Management Members and Securities Affairs Representative, as well as Departure of Core Technical Personnel
- Announcement on the Expiry of Planned Time for Shareholders with Over 5% Shares to Reduce Shares and Results of Shareholding Reduction
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Abnormal Fluctuations in Stock Trading
Follow Sinotherapeutics into a list and get an email when it puts out news.
Follow Sinotherapeutics